单倍体相合造血干细胞移植后细胞免疫重建的动力学的临床研究
被引量:2
摘要
异基因造血干细胞移植(allo-HSCT)属于造血免疫细胞移植,NK细胞是HSCT后最早开始恢复的淋巴细胞亚群.NK细胞受体分子(KIR)在HSCT中与移植物抗宿主病(GVHD)发生以及与移植后复发的关系引人注目[1].异基因供者移植物中的CD4+ CD25+细胞群(Tmg)细胞比例与GVHD发生有关[2-3].我们前期的实验研究发现供者未成熟DC细胞可以防止骨髓移植后GVHD发生而不减弱移植物抗白血病(GVL)效应[4].
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2012年第1期53-55,共3页
Chinese Journal of Hematology
基金
国家自然科学基金(30170395)
参考文献13
-
1段连宁,陈纯,黄绍良,方建培,魏菁,包蓉,李艳,韩红星,李树浓.免疫活性细胞表达杀伤细胞抑制性受体与造血干细胞移植后移植物抗宿主病的关系(英文)[J].中国实验血液学杂志,2003,11(6):625-632. 被引量:6
-
2段连宁,丁丽,闫洪敏,薛梅,刘静,朱玲,王恒湘,纪树荃.单倍体相合骨髓移植后CD4^+CD25^+ T细胞免疫恢复的临床研究[J].中国实验血液学杂志,2010,18(1):177-180. 被引量:5
-
3Taylor PA,Lees C J,Blasar BR.The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.Blood,2002,99:3493-3499.
-
4Xu L,Duan L,Cao K,et al.Predominant immature CD8alpha+dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence.Eur J Haematol,2007,78:235-245.
-
5Ji SQ,Chen HR,Wang HX,et al.G-CSF-primed haploidenticalmarrow transplantation without ex vivo T cell depletion:an excellent alternative for high risk leukemia.Bone Marrow Transplant,2002,30:861-866.
-
6Ruggeri L,Mancusi A,Burchielli E,et al.Natural killer cell alloreactivity and hapo-identical hematopoietic transplantation.Cytotherapy,2006,8:554-558.
-
7Stem M,de Angelis C,Urbani E,et al.Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. Bone Marrow Transplant,2010,45:1607-1610.
-
8Ruggeri L,Capanni M,Casucci M,et al.Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.Blood,1999,94:333-339.
-
9Zhao XY,Huang X J,Liu KY,et al.Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome. Biol Blood Marrow Transplant,2007,13:734-744.
-
10Triplett BM,Horwitz EM,Lyengar R,et al.Effects of activating NK cell receptor expression and NK cell reconstitution on the outcome of unrelated donor hematopoietic cell transplantation for hematologic malignancies.Leukemia,2009,23:1278-1287.
二级参考文献12
-
1Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4 ( + ) CD25 ( + ) immune regulatory cells inhibits graft-versus-host disease lethality. Blood, 2002 ;99 ( 10 ) : 3493 - 3499.
-
2von Boehmer H. Mechanisms of suppression by suppressor T cell. Nat Immunol,2005,6 (4) : 338 - 344.
-
3Eimann J, Hoffmann P, Edinger M, et al. Only the CD62L^+ subpopulation of CD4 ^+ CD25^ + regulatory T cells protects from lethal acute GVHD. Blood ,2005 ; 105 (5) :2220 - 2226.
-
4Stanzani M, Martins SL, Saliba RM, et al. CD25 expression on donor CD4^ + or CD8^+ T ceils is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplan- tation in humans. Blood, 2004;103(3) :1140 -1146.
-
5Meignin V, Peffault de Latour R, Zuber J, et al. Numbers of Foxp3-expressing CD4^ + CD25^high T cells do not correlate with the establishment of long-term tolerance sfter allogeneic stem cell transplantation. Exp Hematol,2005 ;33 ( 8 ) :894 - 900.
-
6Clark FJ, Gregg R, PiperK, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 ^+ CD25^high regulatory T cells. Blood, 2004 ; 103 ( 3 ) : 2410 - 2416.
-
7Edinger M, Hoffmann P, Eimann J, et al. CD4^+ CD25^+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med, 2003 ;9(9) :1144 - 1150.
-
8Jones SC, Murphy GF, Komgold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4CD25 T ceils to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant, 2003 ;9(4) :243 -256.
-
9Nadal E, Garin M, Kaeda J, et al. Increased frequencies of CD4^+ CD25 ( high ) T ( regs ) correlated with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia, 2007 ;21 (3) :472 -479.
-
10陈纯,段连宁,黄绍良,李树浓,魏菁.人脐血T/NK细胞KIR分子表达的初步探讨[J].中山医科大学学报,2002,23(1):67-69. 被引量:5
共引文献9
-
1郑蕊蕊,叶韵斌,陈强.杀伤细胞免疫球蛋白样受体与肿瘤免疫治疗[J].中国肿瘤,2006,15(1):39-42.
-
2段连宁,韩红星,刘静,阎洪敏,朱玲,薛梅,丁丽,朱培瑜,王恒湘,纪树荃.杀伤细胞免疫球蛋白样受体基因及其配体相合或错配对单倍相合骨髓移植效果的影响(英文)[J].中国实验血液学杂志,2007,15(4):809-815. 被引量:5
-
3梁亚丽,祝彼得,马萍.外周造血干细胞诱导器官移植免疫耐受研究[J].现代临床医学,2008,34(6):466-469.
-
4何祎,周征,王荷花,王玫,黄勇,刘庆国,姜尔烈,周世勇,王志东,翟文静,冯四洲,韩明哲.抑制性杀伤细胞受体在NK细胞和T细胞上的表达及其与急性移植物抗宿主病的关系[J].白血病.淋巴瘤,2007,16(2):88-90.
-
5邢春阳,郑树森.杀伤细胞免疫球蛋白样受体在移植中的作用[J].中华移植杂志(电子版),2009,3(1):45-48. 被引量:1
-
6许先国,章伟,洪小珍,刘瑛,陈舒,朱发明,吕杭军,严力行.基于免疫磁珠分选的调节性T细胞亚群嵌合性定量分析[J].中国实验血液学杂志,2010,18(6):1531-1534. 被引量:2
-
7方江春.CD_4^+CD_(25)^+T细胞与急性髓细胞白血病关系的研究[J].中国医药指南,2012,10(34):100-100.
-
8潘妮,董磊.单倍体相合骨髓移植白血病患者造血重建的临床分析和实践[J].泰山医学院学报,2014,35(9):894-895. 被引量:4
-
9郭智,童春,陈惠仁.CD4^+CD25^+调节性T细胞与造血干细胞移植后移植物抗宿主病的相关性[J].中国组织工程研究,2017,21(9):1456-1462. 被引量:3
同被引文献25
-
1蒋盼,汪华.自然杀伤细胞表面受体NKp46的研究进展[J].中华临床医师杂志(电子版),2011,5(22):6711-6714. 被引量:5
-
2于津浦,曹水,辛宁,安秀梅,齐静,任秀宝.低剂量氟达拉滨、环磷酰胺联合供者NK细胞作为非清髓性预处理用于小鼠单倍相合造血干细胞移植[J].中国实验血液学杂志,2007,15(5):1013-1018. 被引量:2
-
3Walzer T, BI 6 ry M, Chaix J, et aL Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 [ J ] . Proc Natl Acad Sci U S A, 2007, 104 ( 9 ) : 3384-3389.
-
4Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation [ J] . Blood, 2001, 97 ( 11 ) : 3380-3389.
-
5Caligiuri MA. Human natural killer cells[ J ]. Blood, 2008, 112( 3 ): 461-469.
-
6Locatelli F, Pende D, Mingari MC, et al. Cellular and molecular basis of baploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias : role of alloreactive NK cells [ J ] . Front Immunol, 2013, 4 : 15.
-
7Lob J, Chu DT, O' guin AK, et al. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegaovirus infection in the spleen and liver [ J ]. J Virol, 2005, 79 ( 1 ) : 661-667.
-
8Arase H, Mocarski ES, Campbell AE, et al. Direct recognition ofcytomegalovirus by activating and inhibitory NK cell receptors [ J ] . Science, 2002, 296 ( 5571 ) : 1323-1326.
-
9Sanos SL, Diefenbach A. Isolation of NK ceils and NK-like cells from the intestinal lamina propria'[ J ] . Methods Mol Biol, 2010, 612 : 505-517.
-
10Small CL, Shaler CR, Mccormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung [ J] . J Immunol, 2010, 184 ( 4 ) : 2048-2056.
引证文献2
-
1雷英英,段连宁,罗渊,郭广进,许鹏飞,陆承荣,王喆,向培德.非清髓单倍体相合骨髓移植后自然杀伤细胞参与急性移植物抗宿主病的免疫病理学研究[J].解放军医学院学报,2014,35(7):725-729.
-
2赵瑾,苏丽萍,关涛,刘小兰,马莉,王晶荣.杀伤细胞免疫球蛋白样受体/人类白细胞抗原受配体模式在单倍型造血干细胞移植中作用的初步探讨[J].白血病.淋巴瘤,2015,24(10):623-624.
-
1唐,贾培敏,吴文,徐岚,赵维莅,阎骅,胡炯,沈志祥.异基因外周血造血干细胞移植后细胞免疫的重建[J].上海交通大学学报(医学版),2006,26(8):922-925. 被引量:4
-
2徐勇,欧阳建,陈兵,周荣富,许景艳,邵晓雁,徐喜慧.单倍体相合造血干细胞移植后合并弥漫性肺泡出血二例报告并文献复习[J].中华血液学杂志,2012,33(8):674-676. 被引量:2
-
3王菲,朱霞明,沈静慧.单倍体相合造血干细胞移植并发急性移植物抗宿主病的护理[J].中国血液流变学杂志,2005,15(4):713-714. 被引量:1
-
4王伟丰,张智峰.脑胶质瘤患者外周血DC细胞的检测及其临床意义[J].实验与检验医学,2017,35(2):196-198. 被引量:1
-
5熊傲雪,张诚,高蕾,张曦,陈幸华,孙爱华.单倍体相合造血干细胞移植后重症移植物抗宿主病的护理[J].国际输血及血液学杂志,2014,37(1):23-25. 被引量:4
-
6刘竞,常英军.单倍体相合造血干细胞移植相关研究进展:第56届美国血液学会年会报道[J].白血病.淋巴瘤,2015,24(3):138-141.
-
7魏璟,李连涛,张媛,李秀华,郭艳玲.自体DC-CIK细胞过继免疫治疗老年癌症患者的护理体会[J].中国伤残医学,2012,20(12):51-51. 被引量:3
-
8林遐,欧莹,龙慧,黄宇贤,宋朝阳,陆志刚,郭坤元,吴秉毅,许剑辉.单倍体相合造血干细胞移植后巨细胞病毒感染可能会减少急性髓系白血病复发[J].中华内科杂志,2016,55(2):107-110.
-
9丁丽,郑晓丽,董磊,韩冬梅,朱恒,闫洪敏,郭子宽,王恒湘,吴祖泽.单倍体相合造血干细胞移植术后早期肺部感染患者CD4^+T细胞功能的分析[J].中国实验血液学杂志,2013,21(4):995-998. 被引量:1
-
10王燕,刘梅,李文萍.自体DC-CIK细胞免疫治疗原发性肝癌的心理护理[J].全科护理,2013,11(3):221-222. 被引量:5